Protein Tyrosine Phosphatase Y (PTPy) inhibitors are a class of small molecules that specifically target and inhibit the activity of the protein tyrosine phosphatase Y, a member of the protein tyrosine phosphatase (PTP) family. PTPy, also known as PTPN22, is an enzyme involved in dephosphorylating tyrosine residues on target proteins, which is a key step in cellular signal transduction pathways. These enzymes play a crucial role in regulating various cellular functions, including cell growth, differentiation, and immune cell signaling. PTPy inhibitors work by binding to the active site of the enzyme, blocking its catalytic activity and preventing it from dephosphorylating its substrates. The specific mechanism of inhibition varies among different compounds in this class, but they generally function through competitive or non-competitive inhibition, either mimicking the natural substrate or interacting with regions of the enzyme that are critical for its function.
The structural diversity of PTPy inhibitors is broad, with different molecules possessing varying degrees of selectivity, potency, and specificity for the target enzyme. Structural motifs typically seen in these inhibitors often include aromatic rings, heterocycles, and functional groups capable of forming hydrogen bonds or ionic interactions with the active site residues of PTPy. Some inhibitors are derived from natural products, while others are synthetic molecules designed based on structure-activity relationship studies. The inhibition of PTPy by these compounds can lead to altered phosphorylation states of key signaling proteins, subsequently affecting downstream pathways. Due to the specificity required for PTPy inhibition, the development and study of these inhibitors often involve detailed biochemical assays to assess their activity, binding affinity, and potential off-target effects on other PTPs or protein kinases, given the structural similarities between family members. The study of PTPy inhibitors is of great interest in understanding the regulation of signaling pathways and elucidating the role of PTPy in various cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibits PTPγ by acting as a transition state analog and competing with the phosphate group of the substrate. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
Binds to vicinal cysteines in the active site, inhibiting PTPγ through the formation of a covalent arsenylated enzyme. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Inhibits PTPγ by binding to the active site and displacing the catalytic cysteine residue. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $153.00 $464.00 | 20 | |
Inhibits PTPγ by mimicking the transition state of the phosphate group during hydrolysis. | ||||||
Batimastat | 130370-60-4 | sc-203833 sc-203833A | 1 mg 10 mg | $179.00 $377.00 | 24 | |
Although primarily a matrix metalloproteinase inhibitor, it could inhibit PTPγ by chelating the active site zinc ion. | ||||||
RWJ-60475 | 204130-08-5 | sc-222266 sc-222266A | 5 mg 25 mg | $153.00 $663.00 | ||
Inhibits PTPγ through competitive inhibition at the active site, although primarily known for inhibiting PTP1B. | ||||||